{
  "trial_id": "NCT01660997",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Histologically or cytologically confirmed Smoldering Multiple Myeloma",
      "label": "met",
      "evidence": "confirmed by the Laboratory of Pathology, NCI based on the International Myeloma Working Group Criteria"
    },
    {
      "criterion": "Serum M-protein greater than or equal to 3 g/dl and/or bone marrow plasma cells greater than or equal to 10 %",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Absence of anemia: Hemoglobin >10 g/dl",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Absence of renal failure: calculated creatinine clearance (according to MDRD) > 80 ml/min",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Age >18 years",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "ECOG performance status <2",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Ability to give informed consent",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Absolute neutrophil count >1.0 K/uL",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Platelets >75 K/uL",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Hemoglobin > 8 g/dL",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Total bilirubin <1.5 X institutional upper limit of normal",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "AST(SGOT)/ALT(SGPT) < 3.0 X institutional upper limit of normal",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients who are receiving any other investigational agents not included in this trial, within 21 days of the start of this trial and throughout the duration of this trial.",
      "label": "triggers",
      "evidence": ""
    },
    {
      "criterion": "Prior therapy for SMM with a proteasome inhibitor.",
      "label": "triggers",
      "evidence": ""
    },
    {
      "criterion": "Patients with a diagnosis of MM.",
      "label": "triggers",
      "evidence": ""
    }
  ],
  "notes": "Patient is a 34-year-old woman from Jordan who comes to clinic with some general and non-specific bones and joints pain. Her past medical and drug history are unremarkable.",
  "_meta": {
    "topic_id": "53",
    "trial_id": "NCT01660997",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}